RENHE PHARMACY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.53 CNY | +0.15% |
|
-0.31% | -1.51% |
| Apr. 29 | Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 26 | Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
ETFs positioned on Renhe Pharmacy Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.21% | 4 M€ | -2.96% | ||
| 0.00% | 34 M€ | +2.67% | - |
RENHE PHARMACY CO.,LTD is a China-based company principally engaged in pharmaceutical industry. The Company is mainly engaged in medical industrial manufacturing and medical merchandising. The Companyâs main products include capsules, granules, tablets, powder, injections, suppositories and ointment, among others. The Company is also involved in the wholesaling and retailing of health-related products. The Company distributes its products mainly in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-24
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -1.51% | 1.26B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B |
- Stock Market
- Equities
- 000650 Stock
- Funds and ETFs Renhe Pharmacy Co., Ltd.
